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Abstract
Rationale Prospective memory (PM) deficits in recreational
drug users have been documented in recent years. However,
the assessment of PM has largely been restricted to self-
reported measures that fail to capture the distinction
between event-based and time-based PM. The aim of the
present study is to address this limitation.
Objectives Extending our previous research, we augmented
the range laboratory measures of PM by employing the
CAMPROMPT test battery to investigate the impact of
illicit drug use on prospective remembering in a sample of
cannabis only, ecstasy/polydrug and non-users of illicit
drugs, separating event and time-based PM performance.
We also administered measures of executive function and
retrospective memory in order to establish whether ecstasy/
polydrug deficits in PM were mediated by group differ-
ences in these processes.
Results Ecstasy/polydrug users performed significantly worse
on both event and time-based prospective memory tasks in
comparison to both cannabis only and non-user groups.
Furthermore, it was found that across the whole sample, better
retrospective memory and executive functioning was associ-
ated with superior PM performance. Nevertheless, this
association did not mediate the drug-related effects that were
observed. Consistent with our previous study, recreational use
of cocaine was linked to PM deficits.
Conclusions PM deficits have again been found among
ecstasy/polydrug users, which appear to be unrelated to
group differences in executive function and retrospective
memory. However, the possibility that these are attributable
to cocaine use cannot be excluded.
Keywords Ecstacy . Cocaine . Cannabis . Prospective
memory . CAMPROMPT
Introduction
Prospective memory (PM) involves remembering to exe-
cute a particular behaviour at some future point in time,
which may be in the short or long term, for example
remembering to turn off the lights when leaving a room or
remembering to attend a meeting, meet a friend or pass on a
message. Self-report measures of this construct have been
developed (e.g. Crawford et al. 2003; Hannon et al. 1995),
and in previous research from our laboratory, Fisk and
co-workers have demonstrated apparent impairments on these
measures among ecstasy/polydrug users (Montgomery and
Fisk 2007) and cannabis-only users (Fisk and Montgomery
2008). Other researchers have also reported deficits on self-
report PM measures among users of illicit drugs (Heffernan
et al. 2001a, b; Rodgers et al. 2001, 2003) and studies from
our own laboratory and elsewhere have revealed deficits
among illicit drug users in laboratory measures of PM
(Hadjiefthyvoulou et al. 2010; Rendell et al. 2007a; Rendell
et al. 2009).
Unsurprisingly, given their role in supporting memory
functions in general, evidence suggests that PM is depen-
dent on medial temporal–hippocampal processes. For
example, in a clinical group with medial temporal sclerosis,
Adda et al. (2008) found that PM performance was
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impaired and that among those with left hemisphere lesions
the degree of impairment was correlated with that in
delayed (7 day) verbal recall on the Rey Auditory Verbal
Learning Task (RAVLT). Leitz et al. (2009) found that PM
performance was significantly correlated with episodic
memory recall following acute administration of alcohol.
In another recent study utilising magnetoencephalography,
Martin et al. (2007) found that that the hippocampal region
was activated longer during both retrospective and pro-
spective memory tasks relative to a control condition.
Interestingly, other regions were also differentially impli-
cated, since compared to the retrospective and control tasks,
the PM task was associated with earlier onset of activation
in the posterior parietal lobe. In an animal study by Goto
and Grace (2008), in which rats searched for food rewards
in a radial maze, prospective and retrospective memory
elements of PM were explored. The results suggested that
the retrospective aspect, although requiring hippocampal
input, also recruits PFC resources before the prospective
component can be activated. Furthermore, the dopaminer-
gic system appeared to differentially support this process
with the D1 receptor apparently supporting the former
aspect and the D2 receptor the latter prospective compo-
nent. Since ecstasy impacts both serotonergic and dopami-
nergic processes, this raises the possibility that disruption of
dopaminergic processes might be responsible for the PM
deficits that have been observed in human drug users.
Aside from its reliance on medial temporal structures, PM
is known to utilise prefrontal executive processes including
the working memory system. Neuroimaging studies have
revealed the involvement of the frontopolar cortex (Brodmann
area 10) and neighbouring prefrontal areas during the
performance of PM tasks (Okuda et al. 2007). Other research
utilising dual-task methodology (Marsh and Hicks 1998),
cognitive ageing paradigms (McDaniel et al. 1999) and
Parkinson’s-related deficits (Kliegel et al. 2005) has also
linked PM functioning to prefrontal-lobe capacity.
It is worthy to note that prospective memory functions may
be defined as either event-based or time-based. For example,
some predefined external event may trigger the retrieval of the
intention to act, or alternatively, the trigger may be the elapse
of a given period of time. There is evidence to suggest that the
two classes utilise neural processes that are at least in part
separable. For example, Burgess et al. (2003) and Gilbert et
al. (2005) have shown that event-based tasks utilise the
frontopolar cortex, including Brodmann area 10 (BA10).
Similar findings were reported by Fleming et al. (2008) in
patients with frontally based traumatic brain injury, particu-
larly in relation to event-based PM. More recently, PET
scanning has revealed that while the left superior frontal
gyrus was involved in both types of tasks, different areas
within this structure were found to be activated. Further-
more, in addition to the frontopolar cortex, the time-based
tasks also activated more diverse regions, including anterior
medial frontal regions, the right superior frontal gyrus and
the anterior cingulate (Okuda et al. 2007). Given the clear
dependence of PM on medial temporal/hippocampal pro-
cesses and on the PFC, it is also clearly of relevance that
ecstasy/polydrug-related deficits have been observed on tasks
supported by these structures, including aspects of executive
functioning (see Murphy et al. 2009 for a review). It would
therefore be of value to determine whether or not the drug-
related deficits in medial temporal processes and in PFC
functions are responsible for the ecstasy/polydrug-related
deficits that have been observed in PM.
While a number of researchers have used self-report
measures to investigate PM deficits among illicit drug users
(Heffernan et al. 2001a, b; Montgomery and Fisk 2007;
Rodgers et al. 2001, 2003), to date, relatively few studies in
this area have used laboratory tests of prospective memory.
McHale and Hunt (2008) administered two simple labora-
tory tests: remembering to press a timer 10 min after being
instructed to do so and remembering to post an envelope
back to the experimenter 2 days after the test session.
Cannabis users were found to be impaired on both of these
measures. A popular recent addition to laboratory measures
of PM is the ‘virtual week’ paradigm. This PM test is a
board game completed in the laboratory, in which the
participant is required to execute previously learned tasks at
specified points as they progress around the board at
specific times or in conjunction with specific events. This
measure has featured in a number of studies. For example,
deficits were observed on this measure among currently
abstinent ecstasy users including those who used infre-
quently (Rendell et al. 2007a). Long-term abstinent
methamphetamine users were also found to be impaired
on the measure relative to a drug naive control group
(Rendell et al. 2009). Furthermore, impairments were also
evident in measures of verbal learning and delayed recall
(RAVLT), forward and backward digit span and the
Hayling Sentence Completion Task (believed to load on
the inhibitory executive process). The extent of the
methamphetamine-related effect in PM was found to co-
vary substantially with the degree of impairment on the
Hayling task (Rendell et al. 2009). In other research
utilising the virtual week, Leitz et al. (2009) demonstrated
that performance was impaired following the acute admin-
istration of alcohol. However, in a subsequent study, the
deficit was eliminated when individuals were instructed
simulate the required actions at the time of encoding (by
imaging the full sensory aspects of the context in which the
action was to be completed; Paraskevaides et al. 2010). The
measure has also been used to investigate the basis of PM
deficits in individuals with mild cognitive impairment and
dementia (Thompson et al. 2010), multiple sclerosis (Rendell
et al. 2007b) and schizophrenia (Henry et al. 2007).
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While the virtual week paradigm has its merits, before
the PM element can be completed, it is necessary to learn
each of the ten particular responses that is paired with
specific locations on the board and select the appropriate
response from among the set of available alternatives each
time a PM action is triggered. This is made easier by the
fact that some responses are common to different tasks.
However, the test clearly has an associative learning
component, and Montgomery et al. (2005a) have demon-
strated that ecstasy users are impaired on paired-associative
learning. Thus, it is possible that some of the deficits
evident on the virtual week might be attributable to this
aspect rather than the PM components. That said, it is
worthy of note that just over half of the virtual week, PM
sub-tasks are regular and more repetitive in nature, and
thus, more readily learned. It is the remaining more
irregular tasks that have a more substantial learning
requirement. Interestingly, ecstasy users performed worse
on these irregular virtual week tasks, recording 65% of the
level of correct responses achieved by non-users, while for
regular tasks, the percentage was 83% (computed from
Table 2; Rendell et al. 2007a). This suggests that
performance is indeed adversely affected by the learning
component. Nonetheless, it must be acknowledged that
there was no statistically significant interaction between
user group and task type with users demonstrating a
significant deficit overall. Thus, while group differences
in learning may partially account for the virtual week
results, the outcomes obtained are nonetheless consistent
with an ecstasy-related PM deficit.
In our previous study (Hadjiefthyvoulou et al. 2010), in
order to minimise the learning requirement, we used a small
number of more simple PM tasks, for each of which only a
single stimulus–response paring needed to be learned. We
also used the Rivermead Behavioural Memory Test (RBMT;
Wilson et al. 1999) battery, which includes three separate
PM tasks. In our study, only one of the three RBMT PM
measures produced statistically significant ecstasy/polydrug-
related deficits. However, the RBMT has been criticised as
lacking the sensitivity to detect memory problems in non-
clinical populations (Spooner and Pachana 2006). Thus, it
may be that the test was not appropriate for the university-
based sample of recreational drug users, which was featured
in our previous study. A more up-to-date test battery that is
sensitive to individual differences, both within clinical and
normal populations, is the Cambridge Prospective Memory
Test (CAMPROMPT; Fleming et al. 2008; Groot et al. 2002;
Wilson et al. 2005). The purpose of the present study is to
confirm and extend our previous findings utilising the more
sensitive CAMPROMPT measure. At the same time, we will
take measures of executive functioning and retrospective
memory in order to establish the extent to which any
ecstasy/polydrug deficits in PM that are uncovered are
mediated by deficits in those memory and executive
functions that are known to underpin PM processes. This
aspect was not addressed in our previous study. A further
innovation in the present study is the inclusion of a
cannabis-only control group (i.e. individuals whose illicit
drug use is restricted to cannabis). Using self-report
measures, we (Fisk and Montgomery 2008) have previ-
ously documented PM deficits among cannabis-only users
(relative to non-users of illicit drugs). However, we have
not previously assessed a cannabis-only user group on
laboratory measures of PM and not in relation to ecstasy/
polydrug users. It is expected that both illicit drug-using
groups will perform worse than non-users of illicit drugs
on the CAMPROMPT measures. No prediction is made in
relation to PM differences between the two illicit drug-
using groups.
Method
Design and analytical strategy
A between-participants design was employed with drug-
using group with three levels (ecstasy/polydrug, cannabis-
only and non-users of illicit drugs) as the independent
variable. The dependent variables were the CAMPROMPT
time and event-based PM scores. Background variables and
the executive and recall measures were also assessed for
group differences.
Pearson’s correlation coefficients were calculated between
the PM measures and the executive and recall measures,
respectively. Regression analyses were conducted with the
PM measures as dependent variables. In each regression,
those variables that were significantly correlated with the PM
measures and any background measures, yielding statistically
significant drug-related differences, were included as predic-
tors. Since the drug use IV had nominal level of measurement,
it was not possible to include it directly in the regression.
Following the procedure outlined by Tabachnick and Fidell
(2007), group differences were incorporated into the regres-
sion by constructing two dichotomous variables. In the first,
ecstasy/polydrug users were coded as ‘1’ and all other
persons coded as ‘0’; in the second, cannabis-only users
were coded as ‘1’ with all other persons coded as ‘0’. In this
way, it was possible to establish whether each group
accounted for statistically significant unique variance while
controlling for the effects of the other predictors.
Participants
Twenty-nine ecstasy/polydrug users (12 females), 12
cannabis-only users (7 females) and 18 non-users of illicit
drugs (16 females) took part in this investigation (for
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demographic details, see Table 1). The gender composition
differed significantly between the groups with females
predominating among the non-illicit user group and males
among the ecstasy/polydrug users, χ2 (N=59, DF=2) =
10.40, p<0.01. Participants were recruited via direct
approach to university students and the snowball technique,
i.e. word-of-mouth referral (Solowij et al. 1992). All
participants were university students attending the Univer-
sity of Central Lancashire (UCLAN) or Liverpool John
Moores University (LJMU).
Materials
A background drug-use questionnaire that has been
previously employed by us (Montgomery et al. 2005b)
assessed the history of illicit drug use and estimated the
total lifetime use, frequency of use, recent consumption, as
well as the period of abstinence for each drug (e.g. ecstasy,
cannabis, amphetamines, cocaine etc.). Fluid intelligence
was measured via Raven’s Progressive Matrices (Raven et
al. 1998), and a further questionnaire assessed the partic-
ipant’s age and gender, the number of years of education
and their current use of alcohol and cigarettes.
Prospective and retrospective memory questionnaire
(PRMQ; Crawford et al. 2003). The PRMQ provides a self-
report measure of prospective and retrospective memory slips
in everyday life. It consists of 16 items, 8 referring to
prospective memory failures, e.g. ‘Do you decide to do
something in a few minutes time and then forget to do it?’
and 8 concerning retrospective failures, e.g. “Do you fail to
recognize a place you have visited before?”. Participants were
asked to specify “how often these things happened to them
on a 5-point scale” very often, quite often, sometimes, rarely,
never. Ratings were subsequently assigned numerical values
of 5 (very often) to 1 (never). A total score for each subscale
(prospective memory and retrospective memory) was also
calculated with minimum score of 8 and maximum score of
40, with higher scores indicative of more memory problems.
Rey Auditory Verbal Learning Test (RAVLT; based on
Rey 1964). The RAVLT is a test developed to evaluate
verbal learning and memory. A list (list A) of 15 words was
presented to the participant orally, with the aid of an audio
recording device, for five consecutive times. At the end of
each trial, the participant was asked to recall as many words
as possible from the list. After the fifth trial, an interference
list (list B), also consisting of 15 words, was read to the
participant, after which she/he was asked to recall as many
words as possible from the interference list. Immediately
following this, the participant was again asked to recall the
words from list A without hearing it again (trial 6). Next,
after a 20-min interval, the participant was asked to
remember the words from list A (trial 7), after which a
recognition test was administered. For the recognition test,
a list consisting of the 15 words from list A and 15
distracter words was read to the participant, and the
individual was asked to indicate whether the word belonged
to list A or not. A number of outcome measures were
produced; first, the total number of words correctly recalled
over trials one to five; second, a measure of proactive
interference (number correct on trial 1 minus number
correct on the interference list); third, retroactive interfer-
ence (number correct on trial 5 minus number correct on
trial 6); and fourth, a measure of decay (number correct on
trial 5 minus number correct on trial 7).
Memory compensation questionnaire (MCQ; Dixon et al.
2001). The MCQ is a 44-item self-report measure assessing
the variety and number strategies the participant uses to
compensate for deficient memory performance. The MCQ is
comprised of seven subscales: external (e.g. “Do you use
shopping lists when you go shopping?”); internal (e.g. “Do
you take your time to go through and reconstruct an event
you want to remember?”); time (e.g. “Do you ask people to
speak slowly when you want to remember what they are
saying?”); reliance (e.g. “When you want to remember an
important appointment, do you ask somebody else (for
example, spouse or friend) to remind you?”); effort (e.g.
“Do you put in a lot of effort when you want to remember an
important conversation with a person?”); success (e.g. “When
you want to remember a newspaper article, is it important to
you to remember it perfectly?”); and change (e.g. “Do you
use such aids for memory as notebooks or putting things in
certain places more or less often today compared to 5–10 year
ago?”). Responses for each item are presented on a five-point
scale, with higher scores representing more frequent use of
the specified compensatory behaviour (1=never, 5=always)
with some items being reversely scored.
Behavior Rating Inventory of Executive Function-Adult
Version (BRIEF-A) (Roth et al. 2005). The BRIEF-A is a
75-item measure of executive function. For each item, the
participant responds on a three-point scale: never, some-
times and often. The measure provides indicators of nine
aspects of executive functions. These map onto two higher
level indices the Behavioral Regulation Index (BRI) and the
Metacognitive Index (MI). The BRI refers to the ability of
the individual to maintain appropriate regulatory control of
their own behaviour and emotional responses and is
comprised of four subscales: inhibit (e.g. “I tap my fingers
or bounce my legs”); shift (e.g. “I have trouble changing
from one activity to another”); emotional control (e.g. “I
have angry outbursts”); and self-monitor (e.g. “I don’t
notice when I cause others to feel bad or get mad until it is
too late”). The MI refers to the individual’s ability to
systematically solve problems through effective planning and
organization. It relates directly to the ability to engage in
active problem solving across a variety of contexts and is
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comprised of five subscales: initiate (e.g. “I need to be
reminded to begin a task even when I am willing”);working
memory (“I have trouble concentrating on tasks (such as
chores, reading or work)”); plan/organize (e.g. “I get over-
whelmed by large tasks”); task monitor (e.g. “I make careless
errors when completing tasks”); and organization of materials
(e.g. “I am disorganized”). For both the BRI and the MI,
higher scores are indicative of more executive dysfunction.
The Cambridge Prospective Memory Test (CAM-
PROMPT) (Wilson et al. 2005). The CAMPROMPT is a
laboratory measure of prospective memory that consists of
a total of six prospective memory tasks, three cued by time
and three cued by events. Participants were asked to work
on some distractor tasks such as word-finder puzzles or a
general knowledge quiz for a 20-min period while they had
to remember to perform the prospective memory tasks. The
participants were allowed to spontaneously use strategies,
such as taking notes, to help them remember. Two of the
three time-based tasks were cued by a countdown kitchen
timer, and the participant had to remind the experimenter
not to forget his/her mug or keys when there were 7 min
left to the end of the session. In the second task, when the
timer showed 16 min, the examiner asked the participant to
remember that “in 7 minutes time”, he/she had to stop
whichever task they were on and change to another. The
third time-based task was cued by a clock. The participant
was asked at a specific time (e.g. 10 past 11; 5 min after the
20-min session) to remind the examiner to ring the
reception/garage. For the event-based tasks, the participant
was asked: (1) to return a book to the examiner when he/
she came to a question about the television program
‘EastEnders’ during the general knowledge quiz; (2) to
return an envelope with “MESSAGE” written on it when
he/she was reminded that there were 5 min left in the test;
and finally, (3) when the examiner informed him/her that
the session was over, to remind the examiner to pick up five
objects that had been hidden at the beginning of the session.
Six points were awarded for each subtask that was
successfully completed, unaided. If the task was completed
after a single general prompt from the experimenter, then
four points were awarded. Alternatively, participants
were awarded two points if a second more specific
prompt was required, one point if after prompting, the
required action was completed on the second attempt and
no point if the participant failed to complete the required
action after prompting. Total scores were then generated
on time-based and event-based subscales, each scoring a
maximum of 18, with higher scores reflecting better
prospective memory performance. The validity and
reliability of the CAMPROMPT has been documented
in a number of studies (i.e. Fleming et al. 2008; Groot et
al. 2002; Wilson et al. 2005).
Procedure
Participants were informed of the purpose of the investigation
and their right to withdraw at any time. After consent had been
obtained, the tests were administered under laboratory
conditions. The drug-use questionnaire (Montgomery et al.
2005b) was administered first followed by the Raven’s
progressive matrices (Raven et al. 1998), the age/education
questionnaire, the PRMQ (Crawford et al. 2003), the MCQ
(Dixon et al. 2001) and the BRIEF-A (Roth et al. 2005)
questionnaires. Finally, the RAVLT and the CAMPROMPT
(Wilson et al. 2005) tests were administered. Participants
were fully debriefed, paid £20 in Tesco store vouchers and
given drug education leaflets. The University of Central
Lancashire’s Ethics Committee approved the study. Data for
the BRIEF-A obtained in the present study have been
included with similar data that were collected previously by
us from another group of participants and are the subject of a
separate publication (Hadjiefthyvoulou et al. 2010). Partic-
ipants also performed a range of other tasks that are beyond
the scope of the present investigation.
Results
As is apparent from inspection of Table 1, with the
exception of tobacco smoking, the groups did not differ
Table 1 Age, intelligence, years of education, cigarette and alcohol use by group
Ecstasy/polydrug users Cannabis-only users Nonusers pa
Mean SD Number Mean SD Number Mean SD Number
Age (years) 21.17 1.79 29 21.92 1.56 12 20.44 2.28 18 ns
Raven’s progressive matrices (maximum 60) 39.21 8.39 29 40.25 7.35 12 40.72 8.90 18 ns
Years of education 15.27 2.44 26 14.92 4.06 12 16.00 2.00 18 ns
Cigarettes per day 7.42 4.48 12 9.00 3.58 6 15.00 − 1 ..017
Alcohol (units per week) 13.41 12.08 27 15.18 12.95 11 9.47 14.70 15 ns
a For one-way ANOVA, except cigarettes where chi-squared test was used
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significantly on any of the background variables. The
proportion of smokers differed significantly between the
groups, χ2 (N=53, df=2)=8.09, p=0.017; however, the
expected frequency in one of the cells, 3.94, was below the
critical value of 5, thus, although there are clear differences
between the groups with 40–50% of illicit drug users
regularly smoking and only one nonuser, the statistical
significance of this outcome cannot be confirmed by chi-
square. The daily consumption of cigarettes did not differ
significantly between ecstasy/polydrug and cannabis-only
users, t (16) = 0.75, p>0.05. Indicators of illicit drug use
may be found in Table 2. It is clear that the ecstasy/
polydrug group used a range of other illicit substances in
addition to ecstasy, including cannabis, cocaine and
ketamine. Furthermore, for all of the measures of drug
use, the median was substantially less than the mean;
indeed, in all cases, the measures exhibited a positive
skew, with a small minority of users demonstrating
relatively high levels of use, while the majority were
clustered around the median. Members of both illicit
drug-using groups had also used poppers (amyl nitrate)
during the preceding 3 months (as had one individual
among the non-illicit drug users). It is worthy of note
that the various indicators of cannabis use did not differ
significantly between the two illicit drug-using groups.
Data screening revealed that there were no univariate
outliers on the PM scores. However, the distribution of the
event-based PM measure deviated significantly from normal
exhibiting a negative skew. Following the data transformation
procedure recommended by Tabachnick and Fidell (2007),
the event-based scores were reflected and the square root
was taken. This means that trends in the transformed variable
are reversed so that higher scores are indicative of worse
performance. Subsequent tests revealed that the distribution
of the transformed variable did not deviate significantly from
normal. Table 3 contains both the untransformed and the
transformed event-based PM measure. However, the analy-
ses reported below relate to the latter.
Inspection of Table 3 reveals that compared to the other
two groups, non-illicit drug users displayed better PM
performance on both the time and event-based measures.
The ecstasy/polydrug users’ scores were the worst, while
cannabis-only users’ scores were between those of the other
two groups. These trends were associated with statistically
significant overall group differences. Subsequent post-hoc
tests revealed that with respect to the event-based PM
Table 2 Indicators of illicit drug use
Ecstasy/polydrug users Cannabis-only users p1
Median Mean SD Number Median Mean SD Number
Total use
Ecstasy (tablets) 194 640.86 1284.99 29 − − − − −
Cannabis (joints) 728 3048.84 5297.53 25 1,118 2242.58 3307.71 12 ns
Cocaine (lines) 416 1037.89 1282.60 19 − − − −
Amount consumed in previous 30 days
Ecstasy (tablets) 0 3.14 8.28 29 − − − − −
Cannabis (joints) 1 26.08 45.80 25 0.50 22.25 33.05 12 ns
Cocaine (lines) 2 8.16 12.74 19 − − − − −
Frequency of use (times per week)
Ecstasy 0.04 0.24 0.43 29 − − − − −
Cannabis 0.25 1.87 2.52 25 0.15 1.86 2.71 12 ns
Cocaine 0.06 0.28 0.36 19 − − − − −
Weeks since last use:
Ecstasy 12 47.00 76.32 29 − − − − −
Cannabis 4 20.34 37.13 25 7.50 73.32 113.69 12 ns
Cocaine 6 15.40 24.36 22 − − − − −
Use of other drugs during the previous 3 months Percent Percent
Amphetamine 3 0
Ketamine 31 8
LSD 3 0
Magic mushrooms 3 0
Poppers 45 17
a For Mann–Whitney U test
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measure, ecstasy/polydrug users performed significantly
worse than the other two groups, which in turn, did not
differ significantly from each other. The only statistically
significant pairwise difference on the time-based PM
measure was with respect to the ecstasy/polydrug group,
which performed significantly worse than the non-illicit
drug users group.
With regard to the BRIEF-A, the MCQ and the RAVLT
measures, two univariate outliers were identified, one on
the decay score of the RAVLT and the other on the change
score of the MCQ. These were replaced by the next highest/
lowest score on the particular measure, plus/minus one
(Tabachnick and Fidell 2007). On the basis of Mahalanobis
distance, no multivariate outliers were detected. Examina-
tion of Table 3 reveals that there were statistically
significant group differences on only two of the non-PM
measures. First, the groups differed significantly on
Crawford et al. (2003) self-report retrospective memory
measure, with ecstasy/polydrug users scoring significantly
worse than non-illicit drug users (neither of the other
pairwise comparisons were statistically significant). Sec-
ond, non-illicit drug users made significantly more use of
external memory aids compared to ecstasy/polydrug users.
The difference between the nonusers and cannabis-only
users on the same measure approached significance.
For the sample as a whole, correlations between the PM
and the other measures are set out in Table 4. The event-
based PM measure was significantly correlated with the
time-based measure (as might be expected). It was also
significantly correlated with two of the retrospective
memory measures: the Crawford et al. (2003) self-report
measure and the recall score on the RAVLT over trials 1–5.
Unsurprisingly, better retrospective memory performance
was associated with better PM performance (High scores on
the Crawford et al. measure are indicative of retrospective
memory problems, while the reverse is true of the time-
based and untransformed event-based PM measures. Hence,
the correlation with the Crawford et al. measure is negative
in the former case and positive in relation to the trans-
formed event-based PM measure.) The correlation between
the ‘Reliance’ subscale on the MCQ and the event-based
PM measure approached statistical significance: as reliance
on others as an aid to memory increased, so PM
performance decreased. Interestingly, the event-based PM
measure was not significantly correlated with either of the
BRIEF-A composite scales. The time-based PM measure,
like the event-based, was significantly correlated with the
Crawford et al. (2003) self-report retrospective memory
measure, and with the recall score on the RAVLT over trials
1–5, the correlation approached significance; in both cases,
better retrospective memory was associated with better
time-based PM performance. The correlation between the
time-based PM measure and the BRIEF-A metacognitive
index also approached statistical significance. Higher
executive functioning was associated with better time-
based PM performance.
In order to evaluate the unique contributions of each of
the predictors to PM performance, two regressions were run
with respectively the transformed event-based PM measure
and the time-based PM measure as dependent variables.
Variables were included as predictors if they were signif-
icantly correlated (in bivariate terms) with the dependent
variable or if they were associated with significant group
differences on the dependent measure. In instances where
the univariate or bivariate outcomes approached statistical
significance, the variables in question were also included as
predictors. The results for the regression analyses are set
out in the penultimate two columns of Table 4. None of the
individual predictors for time-based PM were statistically
significant; however, the overall model accounted for
statistically significant variance (r2=0.285, p<0.05). The
likely implication of this is that there was a degree of
overlapping variance with pairs or larger combinations of
predictors sharing pooled variance with the dependent
variable, making it impossible to allocate statistically
significant unique variance to any one predictor. More
specifically, it is possible that the statistically significant
drug-related PM effects apparent in the ANOVA are in part
mediated by drug-related differences on the other predic-
tors, in particular, aspects of retrospective memory.
Switching the focus to event-based PM, the regression
model accounted for statistically significant variance, (r2=
0.378, p<0.01). Of the individual predictors, the recall
score on the RAVLT over trials 1–5 approached statistical
significance; unsurprisingly, better recall was associated
with better PM performance. Of the other predictors,
ecstasy/polydrug users (relative to other participants)
accounted for statistically significant unique variance
(reflecting the ecstasy/polydrug-related PM deficit). Thus,
it appears that the ecstasy/polydrug effect on event-based
PM cannot be entirely attributed to drug-related differences
in retrospective memory and executive functioning. Sur-
prisingly, the dichotomous gender variable was also
statistically significant as a predictor. Given the manner in
which the variable was coded and the sign of the beta
weight, this would suggest that females were performing
worse than males on the event-based PM task. Paradoxi-
cally, a subsequent t test revealed no statistically significant
gender difference on the event-based PM task, t (57) =
0.13, p>0.05. However, further examination of the gender
differences within the drug-using groups showed that the
gender deficit was only apparent among ecstasy/polydrug
users. Among other participants, females were actually
performing better. This raised the possibility of an
interaction between gender and ecstasy/polydrug use in
determining event-based PM scores. In order to test this
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possibility, the regression was repeated, this time, in
addition to the ecstasy/polydrug and gender variables, their
product was included as an independent variable in order to
establish whether or not there was a statistically significant
interaction. The results are set out in the final column of
Table 4, inspection of which reveals that in this expanded
model, only the interaction between gender and ecstasy/
polydrug use accounts for statistically significant unique
variance. Given the manner in which the dichotomous
variables were coded, the positive beta coefficient indicates
that female ecstasy/polydrug users were especially impaired
on the event-based CAMPROMPT task. By way of clarifica-
tion subsequent analyses revealed that the mean scores for
female ecstasy/polydrug users was 65% higher than that for
female non-ecstasy users, while the equivalent difference for
males was just 16% (as noted above higher scores are
indicative of poorer event-based PM performance).
The incidence of polydrug use among the ecstasy users
makes it difficult to unambiguously attribute the impair-
ments evident in PM to specific illicit drugs. In an attempt
to address this issue, Table 5 contains the simple and partial
correlation coefficients between aspects of drug use on the
one hand and the two PM measures on the other. Where an
individual does not use a specific drug, their usage has
been coded as zero. Inspection of the Table reveals that
only one aspect of drug use is correlated with time-based
PM, i.e. the current frequency of cannabis use. In view of
this outcome, no partial correlations were calculated for
time-based PM. By way of contrast, virtually all aspects of
drug use were correlated with event-based PM. However,
when controls for the use of other illicit drugs were entered,
aspects of ecstasy use were no longer significantly
correlated with event-based PM; rather, it was aspects of
cannabis and cocaine use which yielded statistically
significant correlations.
The illicit drug users among our sample were requested
to refrain from cannabis use for 24 h prior to testing and
from cocaine, ecstasy and other drug use for 7 days prior to
testing. In order to address the possibility that the PM
differences that we observed were due to post-intoxication
effects, we excluded all individuals who indicated that they
had consumed ecstasy, cocaine or cannabis during the
10 days prior to testing. This reduced the size of the
cannabis-only group, thereby reducing statistical power
such that three-way group comparisons were not meaning-
ful. For this reason, the non-illicit drug users and cannabis-
only users were merged to form a single group (drug naive/
cannabis only n=25; ecstasy/polydrug n=14). For the
event-based PM task, the corresponding means (standard
deviations) for the ecstasy/polydrug and combined drug
naive/cannabis-only users were respectively 2.20 (0.73) and
1.69 (0.47) which differed significantly, F(1,37) = 7.10, p<
0.05. For the time-based PM task, the equivalent figures
were respectively 10.92 (3.65) and 14.40 (4.65) which
again differed significantly, F(1,37) = 5.78, p<0.05. Thus,
the ecstasy/polydrug-related PM deficits remained statisti-
cally significant following removal of those persons who
indicated that they had used illicit drugs during the previous
10 days.
Discussion
On the event-based PM measure, ecstasy/polydrug users
were impaired relative to both cannabis-only and nonusers
of illicit drugs. This group was also impaired relative to
nonusers on the time-based measure. While a trend was
evident on both measures with ecstasy/polydrug users
performing worse, cannabis-only users achieving interme-
diate levels of performance and non-illicit drug users
Event-based PMa Time-based PM
Simple correlation Partial correlationb Simple correlation
Cannabis
Total lifetime use 0.246* 0.208 −0.154
Consumed in last 30 days 0.259* 0.230* −0.158
Frequency 0.338** 0.390** −0.286*
Cocaine
Total lifetime use 0.339** 0.328** −0.139
Consumed in last 30 days 0.257* 0.261* −0.126
Frequency 0.403** 0.416*** −0.133
Ecstasy
Total lifetime use 0.261* −0.002 −0.160
Consumed in last 30 days 0.210 −0.036 −0.058
Frequency 0.268* −0.028 −0.065
Table 5 The relationship be-
tween time and event-based PM
and indicators of illicit drug use
***p<0.001; **p<0.01; *p<
0.05; one-tailed
a Correlation for the transformed
variable
b Controlling for the use of other
drugs on the measure in question,
e.g. the correlation between total
use of cannabis and PM control-
ling for the total use of cocaine
and total use of ecstasy
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performing best, cannabis-only users did not differ signif-
icantly from nonusers of illicit drugs on either PM measure.
The ecstasy/polydrug-related deficit observed here in
relation to non-illicit drug users is consistent with previous
findings from our own and other laboratories using self-
report (Hadjiefthyvoulou et al. 2010; Heffernan et al.
2001a, b; Montgomery and Fisk 2007; Rodgers et al.
2001, 2003) and laboratory measures (Hadjiefthyvoulou et
al. 2010; Rendell et al. 2007a). They also demonstrate the
utility of the CAMPROMPT measure in detecting individ-
ual differences in PM performance among non-clinical
populations augmenting the existing literature in this regard
(Groot et al. 2002; Wilson et al. 2005).
For the most part, ecstasy/polydrug deficits were not
evident on the other measures that were administered. Deficits
were only evident on the retrospective memory questionnaire
and nonusers of illicit drugs were significantly more likely to
report using external memory aids in everyday contexts.
Cannabis-only users did not differ significantly from either of
the other two groups on any of the non-PM measures.
For the sample as a whole, individual differences on
both PM measures were significantly correlated with
outcomes on the retrospective memory questionnaire and
with the RAVLT recall scores for the first five trials. In both
cases, better retrospective memory was associated with
better PM performance. Scores on the BRIEF-A metacog-
nitive index were also related to performance on the time-
based PM task with better executive functioning associated
with improved PM performance; however, this trend only
approached statistical significance two-tailed (although
given the directional nature of the anticipated effect, the
outcome is statistically significant on a one-tailed basis).
These findings are consistent with the outcomes reported
above linking PM performance with medial temporal
functioning (Adda et al. 2008; Martin et al. 2007) and with
PFC processes (e.g. Okuda et al. 2007).
In order to establish the extent to which drug-related
deficits on the PM tasks were mediated by deficits in
retrospective memory and executive functions, regressions
were run with each of the PM variables as the criterion. For
the time-based PM task, the dummy variable representing
the effects of ecstasy/polydrug use was not statistically
significant as a predictor. Indeed, although the model as
a whole accounted for statistically significant variance,
none of the individual predictors were statistically
significant. This suggests that any effects associated with
ecstasy/polydrug use covary with individual differences
in the other predictors and with the criterion leaving
open the question of whether drug use per se adversely
affects time-based PM.
The regression analysis for event-based PM yielded
different results with only ecstasy/polydrug use and gender,
accounting for statistically significant unique variance. A
further regression revealed that the two predictors, in fact,
significantly interacted, such that the ecstasy/polydrug-
related deficit was most pronounced amongst female users.
Indeed, neither of the main effects was statistically significant
in the amended model. Of the other predictors in the model,
the RAVLT recall scores for the first five trials approached
statistical significance. It is noteworthy that the sum of the
squared semi-partial correlation coefficients (0.139) is far less
than the overall R-squared value (0.431), indicating that most
of the explained variance in the criterion reflects the over-
lapping effects of two or more predictors.
The emergence of gender-specific illicit drug-related
effects is not without precedent. For example, women who
were heavy users of cannabis were impaired relative to
female light users on visuo-spatial memory, while no such
deficit emerged among male cannabis users (Pope et al.
1997). Gender was also found to moderate the extent of
ecstasy-related deficits in design fluency (with female users
exhibiting a deficit, while male users actually performed
better than controls), although it was not a moderating
factor on deficits observed in verbal learning (Medina et al.
2005). Reneman et al. (2001) found that female ecstasy
users exhibited a larger reduction in serotonin transporter
densities relative to males. However, in a subsequent study
in which ecstasy users were found to be impaired in various
aspects of memory performance, female users were not
significantly more affected than male users (Reneman et al.
2006). It is also worthy of note that the gender–drug use
interaction only emerged on event-based PM tasks and not
on the time-based PM measure. Thus, the apparent gender
difference observed in the present study should be treated
with a degree of caution.
While deficits in aspects of PM are clearly evident
among ecstasy/polydrug users, what is less clear is which
illicit drug or drugs may be responsible for these deficits. It
is striking that when the use of other drugs is controlled
through partial correlation, no aspect of ecstasy use is
statistically significant as a predictor of PM performance. It
is also worthy of note that while cannabis-only users were
not significantly impaired relative to non-illicit drug users,
they did performance worse on both PM measures
compared with controls, and cannabis use among the whole
sample was significantly correlated with event-based PM
even following statistical controls for the effects of other
illicit drugs. Higher levels of consumption during the
previous 30 days and increasing frequency of use were
associated with poorer event-based PM performance. Thus,
the present results suggest that cannabis use does adversely
affect PM performance, although the effect may be accentu-
ated among polydrug users. The present results augment those
of other studies in which cannabis-related PM deficits have
been observed, (e.g. Fisk and Montgomery 2008; McHale
and Hunt 2008; Rodgers et al. 2003).
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A striking feature of the present results was that cocaine
use was significantly correlated with event-based PM
performance even following statistical controls for the use
of other illicit drugs. Increasing lifetime dose, greater
consumption during the previous 30 days and an increased
frequency of use are all associated with poorer event-based
PM performance. This replicates the results of our previous
study (Hadjiefthyvoulou et al. 2010), this time, with a
different sample and with an alternative laboratory-based
PM measure. As far as we are aware, the present study and
our previous one are the first to link the recreational use of
cocaine with prospective memory deficits. The mechanisms
through which cocaine might adversely affect PM functions
remain unclear. On the basis of the results from their fMRI
study, Tomasi et al. (2007) argue that a prior history of
cocaine use disrupts the operation of those dopaminergic
systems in the prefrontal cortex, which underpin executive
functioning. Given the key role of executive functions in
supporting PM processes, this might account for the adverse
association between cocaine use and PM functioning.
It is also noteworthy that PM deficits have been observed in
Parkinson’s patients (Kliegel et al. 2005), and since the disease
is characterised by disruption of dopaminergic functioning in
the corticostriatal pathway, this is consistent with a direct role
for dopamine in supporting PM functions. Evidence, consis-
tent with this proposition, emerged in a recent study by Costa
et al. (2008), in which administration of L-dopa significantly
improved PM performance in a sample of Parkinson’s
patients relative to an unmedicated condition. As noted
above, animal studies have also suggested a direct role for
mesocortical dopaminergic systems in supporting prospective
memory processes (Goto and Grace 2008). Since it is known
that both cocaine and ecstasy potentially disrupt the func-
tioning of dopaminergic systems, it is possible that the basis
of the prospective memory deficits observed in the present
study reside in impaired dopaminergic processes in the
corticostriatal pathway.
A further possibility is that cocaine might give rise to
impairment in medial temporal and hippocampal processes.
In a recent study, Fox et al. (2009) found that performance
on various aspects of the RAVLT was impaired among an
inpatient cocaine-dependent group. Relative to controls,
deficits were related to self-report stress levels and within
the cocaine-dependent group with raised early morning
cortisol levels. Fox et al. attribute the stress-related increase
in cortisol levels and the associated memory deficits to
hippocampal damage stemming from cocaine use. If this
were the case, in the present context, the recall component
of PM performance might be compromised among recrea-
tional cocaine users, thereby accounting for the results
obtained here.
A number of limitations can be identified for this study.
First, as with many studies in this area, no objective
measure of recent drug use, such as urinalysis or hair
analysis, was used. Thus, the period of abstinence cannot
be objectively verified. Also, the purity of the ecstasy
tablets or any other consumed drug cannot be guaranteed,
making it still more difficult to attribute the effects
observed here to specific psychoactive drugs. Another
important factor that should not be overlooked is that the
apparent ecstasy/polydrug-related deficits may not neces-
sarily be a consequence of illicit drug use but instead be
due to pre-existing differences between users and nonusers
originating before the onset of illicit drug use. In addition,
the possibility that current lifestyle differences or the effects
of illicit drug use on other physiological processes (e.g.
impaired sleep quality) might be the actual cause of the
deficits observed in the current study cannot be entirely
excluded. A methodological issue that needs to be
considered is the relatively small sample size in the present
study, which means that the results of the regression
analyses need to be treated with caution. Indeed, before
definitive statements can be made regarding the relative
importance of individual predictors, the regression analysis
would need to be replicated with a substantially larger
sample. Nonetheless, the present results are potentially
informative as a guide for which variables might be
incorporated into future research, utilising larger samples.
Other methodological aspects of the present study might
warrant a different approach in future research. For
example, we used a self-report measure of executive
functioning rather than laboratory-based measures. It might
have been desirable to incorporate laboratory-based tests of
executive functioning; however, recent conceptualisations
of executive functioning have emphasised the non-unitary
nature of these processes, identifying four or more
separable processes: updating, inhibition, switching and
access to semantic memory (Fisk and Sharp 2004; Miyake
et al. 2000) each with a number of specific measures.
Furthermore, ecstasy/polydrug users appear to be differen-
tially affected on each of these (Montgomery et al. 2005b).
Thus, the inclusion of such a comprehensive test battery
would have substantially expanded the length of the test
session and was not possible given the resource constraints
of the present study. Nonetheless, future research might
incorporate such measures, perhaps utilising latent variable
analysis, in order to evaluate the potential role of the
various executive component processes with respect to a
range of different PM measures.
To conclude, the present study intended to determine the
impact of ecstasy/polydrug use and cannabis use on event-
based and time-based prospective memory using the
CAMPROMPT. Measures of executive functioning and
retrospective memory were also administered in order to
study the extent to which executive processes account for
the prospective memory deficits in recreational drug users.
772 Psychopharmacology (2011) 215:761–774
Relative to both drug-naive persons and cannabis-only
users, ecstasy/polydrug users performed significantly worse
on both event-based and time-based prospective memory
tasks, while no significant differences in performance were
observed between the cannabis user and nonuser groups.
However, consistent with the results of our previous study,
recreational use of cocaine was significantly correlated with
event-based prospective memory performance, demonstrat-
ing the need for a systematic investigation of the potential
role of cocaine in accounting for the PM deficits that have
been observed here and in other studies.
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